Human T-cell lymphotropic virus type 1 transmission dynamics in rural villages in the Democratic Republic of the Congo with high nonhuman primate exposure.
Adolescent
Animals
Animals, Wild
/ virology
Child
Democratic Republic of the Congo
Family Characteristics
Female
HTLV-I Infections
/ transmission
Human T-lymphotropic virus 1
/ classification
Human T-lymphotropic virus 2
Humans
Monkey Diseases
/ transmission
Phylogeny
Primates
/ virology
Proviruses
Public Health
Retroviridae Infections
/ transmission
Simian T-lymphotropic virus 1
Surveys and Questionnaires
Viral Load
Zoonoses
/ transmission
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
14
07
2020
accepted:
26
10
2020
revised:
09
02
2021
pubmed:
29
1
2021
medline:
18
5
2021
entrez:
28
1
2021
Statut:
epublish
Résumé
The Democratic Republic of the Congo (DRC) has a history of nonhuman primate (NHP) consumption and exposure to simian retroviruses yet little is known about the extent of zoonotic simian retroviral infections in DRC. We examined the prevalence of human T-lymphotropic viruses (HTLV), a retrovirus group of simian origin, in a large population of persons with frequent NHP exposures and a history of simian foamy virus infection. We screened plasma from 3,051 persons living in rural villages in central DRC using HTLV EIA and western blot (WB). PCR amplification of HTLV tax and LTR sequences from buffy coat DNA was used to confirm infection and to measure proviral loads (pVLs). We used phylogenetic analyses of LTR sequences to infer evolutionary histories and potential transmission clusters. Questionnaire data was analyzed in conjunction with serological and molecular data. A relatively high proportion of the study population (5.4%, n = 165) were WB seropositive: 128 HTLV-1-like, 3 HTLV-2-like, and 34 HTLV-positive but untypeable profiles. 85 persons had HTLV indeterminate WB profiles. HTLV seroreactivity was higher in females, wives, heads of households, and increased with age. HTLV-1 LTR sequences from 109 persons clustered strongly with HTLV-1 and STLV-1 subtype B from humans and simians from DRC, with most sequences more closely related to STLV-1 from Allenopithecus nigroviridis (Allen's swamp monkey). While 18 potential transmission clusters were identified, most were in different households, villages, and health zones. Three HTLV-1-infected persons were co-infected with simian foamy virus. The mean and median percentage of HTLV-1 pVLs were 5.72% and 1.53%, respectively, but were not associated with age, NHP exposure, village, or gender. We document high HTLV prevalence in DRC likely originating from STLV-1. We demonstrate regional spread of HTLV-1 in DRC with pVLs reported to be associated with HTLV disease, supporting local and national public health measures to prevent spread and morbidity.
Identifiants
pubmed: 33507996
doi: 10.1371/journal.pntd.0008923
pii: PNTD-D-20-01273
pmc: PMC7872225
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0008923Subventions
Organisme : NIAID NIH HHS
ID : K01 AI074810
Pays : United States
Commentaires et corrections
Type : ErratumIn
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist. Author Jean-Jacques Muyembe was unable to confirm their authorship contributions. On their behalf, the corresponding author has reported their contributions to the best of their knowledge.
Références
Bull Acad Natl Med. 2013 Dec;197(9):1655-67; discussion 1667-8
pubmed: 26137812
J Clin Microbiol. 2000 Nov;38(11):4049-57
pubmed: 11060067
Transfusion. 2000 Apr;40(4):443-9
pubmed: 10773057
Antiviral Res. 2017 Jan;137:41-48
pubmed: 27840202
Lancet. 2018 May 12;391(10133):1893-1894
pubmed: 29781438
Ecohealth. 2017 Mar;14(1):100-114
pubmed: 28050688
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Braz J Infect Dis. 2018 May - Jun;22(3):224-234
pubmed: 29879426
J Infect Dis. 2015 Feb 1;211(3):361-5
pubmed: 25147276
PLoS Negl Trop Dis. 2018 Oct 1;12(10):e0006812
pubmed: 30273350
Virology. 2017 Apr;504:141-151
pubmed: 28193549
Virology. 1994 Jul;202(1):212-23
pubmed: 8009833
PLoS One. 2013 Oct 08;8(10):e77072
pubmed: 24116202
Infect Genet Evol. 2016 Sep;43:434-50
pubmed: 27245152
J Gen Virol. 2017 Apr;98(4):835-846
pubmed: 28150581
Trop Med Int Health. 2019 Nov;24(11):1277-1290
pubmed: 31465629
Virology. 1998 Jul 5;246(2):277-87
pubmed: 9657946
PLoS One. 2016 Jun 16;11(6):e0157709
pubmed: 27310836
J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 15;8(5):511-5
pubmed: 7697449
J Virol. 2014 Sep 1;88(17):9782-8
pubmed: 24942582
Lancet. 2004 Mar 20;363(9413):932-7
pubmed: 15043960
Virology. 2011 Feb 5;410(1):48-55
pubmed: 21087785
Science. 2003 Oct 10;302(5643):276-8
pubmed: 12958366
PLoS Negl Trop Dis. 2018 Oct 25;12(10):e0006833
pubmed: 30359373
J Med Virol. 1994 Sep;44(1):104-9
pubmed: 7798879
J Acquir Immune Defic Syndr (1988). 1993 Jul;6(7):840-4
pubmed: 8509984
Curr HIV/AIDS Rep. 2018 Apr;15(2):182-189
pubmed: 29460226
Retrovirology. 2012 Dec 05;9:100
pubmed: 23217108
Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):19653-6
pubmed: 22106297
Emerg Infect Dis. 2012 May;18(5):830-3
pubmed: 22516514
Virology. 1994 Jul;202(1):379-89
pubmed: 7912021
Transfusion. 1990 Jul-Aug;30(6):491-4
pubmed: 1974089
Front Microbiol. 2012 Nov 15;3:388
pubmed: 23162541
Science. 2000 Jan 28;287(5453):607-14
pubmed: 10649986
Ecohealth. 2014 Dec;11(4):534-43
pubmed: 24845574
J Med Virol. 2011 Jul;83(7):1269-74
pubmed: 21567429
Nucleic Acids Res. 2015 Jul 1;43(W1):W7-14
pubmed: 25883146
Virus Evol. 2016 May 25;2(1):vew011
pubmed: 27774304
Virology. 2013 Jan 5;435(1):187-99
pubmed: 23217627
Proc Natl Acad Sci U S A. 2005 May 31;102(22):7994-9
pubmed: 15911757
AIDS Res Hum Retroviruses. 2000 Dec 10;16(18):2043-8
pubmed: 11153087
Emerg Infect Dis. 2017 Sep;23(9):1446-1453
pubmed: 28820130
J Infect Dis. 1990 Jun;161(6):1073-7
pubmed: 2345292
Emerg Infect Dis. 2005 Dec;11(12):1822-7
pubmed: 16485465
J Virol. 2006 Jan;80(2):663-70
pubmed: 16378969
AIDS Res Hum Retroviruses. 1994 Sep;10(9):1135-42
pubmed: 7826698
AIDS Res Hum Retroviruses. 2003 Mar;19(3):255-8
pubmed: 12698951
Virology. 2010 Jun 5;401(2):137-45
pubmed: 20353873
J Neurol Neurosurg Psychiatry. 1990 Jan;53(1):4-10
pubmed: 2303831
AIDS Res Hum Retroviruses. 2003 Jun;19(6):519-23
pubmed: 12892061
Retrovirology. 2005 May 09;2:30
pubmed: 15882466
Retrovirology. 2016 Aug 12;13(1):56
pubmed: 27519553
Iran J Basic Med Sci. 2013 Mar;16(3):208-12
pubmed: 24470863
Ecohealth. 2017 Sep;14(3):552-563
pubmed: 28831639
Retrovirology. 2019 Dec 16;16(1):39
pubmed: 31842895
J Med Virol. 2018 Feb;90(2):351-357
pubmed: 28876483
Oncogene. 2005 Sep 5;24(39):5996-6004
pubmed: 16155606
Virology. 2001 Sep 1;287(2):275-85
pubmed: 11531406
AIDS Res Hum Retroviruses. 2013 Feb;29(2):359-64
pubmed: 22894552
J Virol. 1997 Feb;71(2):1317-33
pubmed: 8995656
PLoS One. 2010 Mar 10;5(3):e9490
pubmed: 20224823
Int J Cancer. 2020 Apr 15;146(8):2089-2103
pubmed: 31254479
Pathol Biol (Paris). 2009 Mar;57(2):161-6
pubmed: 18456423
J Virol. 2017 Apr 28;91(10):
pubmed: 28298599
J Gen Virol. 2004 Feb;85(Pt 2):507-519
pubmed: 14769908
Ecohealth. 2017 Mar;14(1):115
pubmed: 28258524
J Clin Virol. 2011 Sep;52(1):38-44
pubmed: 21704554
Clin Infect Dis. 2016 Sep 15;63(6):800-803
pubmed: 27325689
J Med Virol. 1997 May;52(1):1-7
pubmed: 9131450
J Virol. 2010 Aug;84(15):7427-36
pubmed: 20484508
J Gen Virol. 2003 Oct;84(Pt 10):2723-2727
pubmed: 13679606
J Acquir Immune Defic Syndr. 2018 Dec 15;79(5):543-550
pubmed: 30222659
Transfusion. 2006 Sep;46(9):1647-8
pubmed: 16965596
J Clin Virol. 2013 Nov;58(3):584-6
pubmed: 24095029
AIDS Res Hum Retroviruses. 2012 Jun;28(6):628-35
pubmed: 21827287
Emerg Infect Dis. 2009 Feb;15(2):175-84
pubmed: 19193260
Retrovirology. 2009 Oct 27;6:97
pubmed: 19860877
Clin Infect Dis. 2015 Jun 1;60(11):1667-76
pubmed: 25722199